TERESA MCNEANY: Open Payments
NPI 1063999571 · NOBLESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,756 in 81 payments from 22 companies in 2025. Trend: 2023 $1,644 · 2024 $1,840 · 2025 $1,756
Food & beverage: $1,667Education: $89
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $355 |
| GlaxoSmithKline, LLC. | 21 | $260 |
| GENZYME CORPORATION | 10 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $124 |
| Verona Pharma, Inc. | 6 | $111 |
| SANOFI-AVENTIS U.S. LLC | 1 | $89 |
| JAZZ PHARMACEUTICALS INC. | 3 | $85 |
| Insmed, Inc. | 4 | $81 |
| Viatris Specialty LLC | 3 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
Products named: DUPIXENT, NUCALA, BREZTRI, GLASSIA, TEZSPIRE, Ohtuvayre, XYWAV, Arikayce.
Industry payments across IN — which companies pay providers there.
